Drug intelligence / Profile preview

fgf1 + CPP-C (f02e60)

Development stage
Preclinical
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Administration
Intraperitoneal
01

Overview

FGF1/CPP-C is a research-stage chimeric fusion protein consisting of Fibroblast Growth Factor 1 (FGF1) linked to a cell-penetrating peptide (CPP-C). It was engineered to enhance the intracellular signaling mode of FGF1 while bypassing or inhibiting the activation of cell-surface Fibroblast Growth Factor Receptors (FGFRs). This design aims to provide radioprotective effects, such as promoting crypt survival and DNA repair in the intestine following carbon ion radiotherapy, without the risk of promoting cancer malignancy typically associated with native FGF1's activation of surface FGFRs. In preclinical models, FGF1/CPP-C has demonstrated the ability to inhibit the proliferation, invasion, and migration of pancreatic carcinoma cell lines (MIAPaCa-2 and PANC-1) by internalizing FGF1 to exert suppressive intracellular effects.

Other names
FGF1-CPP-C chimeric proteinFGF-1-CPP-C chimeric proteinFGF 1-CPP-C chimeric protein
02

Targets

FGFR4 (Fibroblast growth factor receptor 4)HS (Heparan sulfate)GAGs/aPLs (Cell-surface glycosaminoglycans and anionic phospholipids)FGFR3 (Fibroblast growth factor receptor 3)FGFR2 (Keratinocyte growth factor receptor)FGFR1 (Fibroblast growth factor receptor 1)

Beyond the preview

Go deeper on fgf1 + CPP-C (f02e60).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fgf1 + CPP-C (f02e60).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call